New AI research helps VCs vet ideas 10x faster Vela Partners and the University of Oxford publish new research about how venture capitalists can use artificial intelligence to vet ideas 10x faster.

180 Life Sciences and University of Oxford Announce Publication of Positive Phase 2b Dupuytren’s Disease Study Results in The Lancet Rheumatology The study achieved the primary endpoint of reduction in nodule hardness at 12 months and secondary endpoint of reduction in nodule size at multiple time points including 12 monthsThe treatment arm...

Blue Water Vaccines Presents New Data Supporting Universal Influenza Vaccine Candidate at the World Vaccine Congress 2022 in Washington, DC CINCINNATI, April 21, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or “the Company”), a biopharmaceutical company developing transformational vaccines, today...

Blue Water Vaccines Inc to Present at World Vaccine Congress Washington 2022 BWV-101 - Universal Influenza Program: Developing a novel vaccine to protect against all influenza strains using groundbreaking mathematical models and research CINCINNATI, April 11, 2022 (GLOBE...

University of Oxford Wins Kira Talent's Best Higher Education Recruitment Award TORONTO, March 06, 2018 (GLOBE NEWSWIRE) -- The University of Oxford's international graduate recruitment video has been selected as this year's recipient of the Kira Award for Best Higher Education...